As of 2026-01-07, the EV/EBITDA ratio of Maravai LifeSciences Holdings Inc (MRVI) is -17.02. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRVI's latest enterprise value is 1,072.73 mil USD. MRVI's TTM EBITDA according to its financial statements is -63.03 mil USD. Dividing these 2 quantities gives us the above MRVI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 17.6x | 15.8x |
| Forward P/E multiples | 19.1x - 27.2x | 21.6x |
| Fair Price | (5.02) - (4.64) | (4.91) |
| Upside | -229.5% - -219.7% | -226.6% |
| Date | EV/EBITDA |
| 2026-01-02 | -14.89 |
| 2025-12-31 | -14.46 |
| 2025-12-30 | -14.54 |
| 2025-12-29 | -14.79 |
| 2025-12-26 | -14.54 |
| 2025-12-24 | -14.67 |
| 2025-12-23 | -14.63 |
| 2025-12-22 | -15.48 |
| 2025-12-19 | -15.19 |
| 2025-12-18 | -15.56 |
| 2025-12-17 | -15.32 |
| 2025-12-16 | -15.84 |
| 2025-12-15 | -16.17 |
| 2025-12-12 | -15.88 |
| 2025-12-11 | -16.33 |
| 2025-12-10 | -16.41 |
| 2025-12-09 | -16.25 |
| 2025-12-08 | -15.92 |
| 2025-12-05 | -16.29 |
| 2025-12-04 | -16.29 |
| 2025-12-03 | -15.52 |
| 2025-12-02 | -15.23 |
| 2025-12-01 | -14.99 |
| 2025-11-28 | -15.96 |
| 2025-11-26 | -16.05 |
| 2025-11-25 | -16.53 |
| 2025-11-24 | -16.21 |
| 2025-11-21 | -16.49 |
| 2025-11-20 | -15.15 |
| 2025-11-19 | -15.48 |
| 2025-11-18 | -15.96 |
| 2025-11-17 | -14.83 |
| 2025-11-14 | -16.05 |
| 2025-11-13 | -14.46 |
| 2025-11-12 | -14.46 |
| 2025-11-11 | -14.46 |
| 2025-11-10 | -13.85 |
| 2025-11-07 | -12.92 |
| 2025-11-06 | -13.00 |
| 2025-11-05 | -12.92 |
| 2025-11-04 | -12.92 |
| 2025-11-03 | -13.21 |
| 2025-10-31 | -14.02 |
| 2025-10-30 | -14.02 |
| 2025-10-29 | -13.73 |
| 2025-10-28 | -14.38 |
| 2025-10-27 | -14.83 |
| 2025-10-24 | -15.11 |
| 2025-10-23 | -15.40 |
| 2025-10-22 | -15.11 |